Phase 1 Relapsed or Refractory Multiple Myeloma (RRMM) Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
Relapsed or Refractory Multiple Myeloma (RRMM)
Beijing GoBroad Hospital18 enrolled1 locationNCT07003568
Recruiting
Phase 1
Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
Relapsed or Refractory Multiple Myeloma (RRMM)
Beijing GoBroad Hospital18 enrolled1 locationNCT07003555
Recruiting
Phase 1Phase 2
Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma (RRMM)
Chengdu Zenitar Biomedical Technology Co., Ltd144 enrolled1 locationNCT06484829